It is humbling to present trials that advance care for patients to our colleagues from across the world – SCRI Oncology Partners

SCRI Oncology Partners recently shared on LinkedIn:

“SCRI Oncology Partners and Sarah Cannon Research Institute physicians just got back from ASCO24.

It is humbling to be able to present data from these trials that advance care for patients to our colleagues from across the world.

It also fills us with gratitude for our patient volunteers on trials that partner with us to make treatments better for tomorrow. It is so exciting that patients can access the newest therapies right here in Nashville!

Across multiple disease subtypes – breast, GI, lung, GU, melanoma, GYN, H&N, and phase I rare tumors we were very encouraged about new afar from this year!”

Source: SCRI Oncology Partners/LinkedIn